Literature DB >> 16492283

Ochronosis and aortic valve stenosis.

Jagdish W Butany1, Ather Naseemuddin, Yaron Moshkowitz, Vidhya Nair.   

Abstract

Valvular heart disease has numerous etiologies. These range from congenital malformations to infectious and degenerative diseases. Clinically, these result in significant problems, the management of which can necessitate valve replacement with prosthetic heart valves. A rare cause is the deposition of foreign material in the valvular tissues, and these include inborn errors of metabolism of the essential amino acids. Alkaptonuria, an autosomal recessive trait, can result in the accumulation of excess homogentisic acid. This can manifest as pigmentation in the skin and other tissues, including heart valves. Accumulation of this pigment can lead to an inflammatory reaction and to progressive valve dysfunction.

Entities:  

Mesh:

Year:  2006        PMID: 16492283     DOI: 10.1111/j.1540-8191.2006.00207.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  10 in total

1.  Ochronotic involvement of the aortic and mitral valves in a 72-year-old man.

Authors:  Atakan Atalay; Ugur Gocen; Yuksel Basturk; Erkan Kozanoglu; Hafize Yaliniz
Journal:  Tex Heart Inst J       Date:  2015-02-01

2.  Aortic stenosis and vascular calcifications in alkaptonuria.

Authors:  Hwaida Hannoush; Wendy J Introne; Marcus Y Chen; Sook-Jin Lee; Kevin O'Brien; Pim Suwannarat; Michael A Kayser; William A Gahl; Vandana Sachdev
Journal:  Mol Genet Metab       Date:  2011-10-30       Impact factor: 4.797

3.  Ochronosis with cardiovascular involvement: a case report.

Authors:  Serpil Bal; Yasemin Turan; Hikmet Koçyiğit; Alev Gürgan; Sükran Kurtulmuş; Anil Güvenç; Gonca Deniz
Journal:  Rheumatol Int       Date:  2007-09-25       Impact factor: 2.631

4.  Muscleblind-like 1 is required for normal heart valve development in vivo.

Authors:  Ryan J Coram; Samantha J Stillwagon; Anuradha Guggilam; Michael W Jenkins; Maurice S Swanson; Andrea N Ladd
Journal:  BMC Dev Biol       Date:  2015-10-15       Impact factor: 1.978

5.  Absorbance measurements of oxidation of homogentisic acid accelerated by the addition of alkaline solution with sodium hypochlorite pentahydrate.

Authors:  Yasunori Tokuhara; Kenichi Shukuya; Masami Tanaka; Keisuke Sogabe; Yasukazu Ejima; Sho Hosokawa; Hiroyuki Ohsaki; Tatsuya Morinishi; Eiichiro Hirakawa; Yutaka Yatomi; Tatsuo Shimosawa
Journal:  Sci Rep       Date:  2018-07-27       Impact factor: 4.379

6.  Ochronosis as an unusual cause of valvular defect: a case report.

Authors:  Andreas Wilke; Dietmar Steverding
Journal:  J Med Case Rep       Date:  2009-11-27

7.  Alkaptonuria is a novel human secondary amyloidogenic disease.

Authors:  Lia Millucci; Adriano Spreafico; Laura Tinti; Daniela Braconi; Lorenzo Ghezzi; Eugenio Paccagnini; Giulia Bernardini; Loredana Amato; Marcella Laschi; Enrico Selvi; Mauro Galeazzi; Alessandro Mannoni; Maurizio Benucci; Pietro Lupetti; Federico Chellini; Maurizio Orlandini; Annalisa Santucci
Journal:  Biochim Biophys Acta       Date:  2012-07-28

8.  Detection of novel visible-light region absorbance peaks in the urine after alkalization in patients with alkaptonuria.

Authors:  Yasunori Tokuhara; Kenichi Shukuya; Masami Tanaka; Mariko Mouri; Ryunosuke Ohkawa; Midori Fujishiro; Tomoo Takahashi; Shigeo Okubo; Hiromitsu Yokota; Makoto Kurano; Hitoshi Ikeda; Seiji Yamaguchi; Shinobu Inagaki; Mika Ishige-Wada; Hiromi Usui; Yutaka Yatomi; Tatsuo Shimosawa
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

9.  Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient.

Authors:  Lia Millucci; Lorenzo Ghezzi; Eugenio Paccagnini; Giovanna Giorgetti; Cecilia Viti; Daniela Braconi; Marcella Laschi; Michela Geminiani; Patrizia Soldani; Pietro Lupetti; Maurizio Orlandini; Chiara Benvenuti; Federico Perfetto; Adriano Spreafico; Giulia Bernardini; Annalisa Santucci
Journal:  Mediators Inflamm       Date:  2014-04-28       Impact factor: 4.711

10.  [Anesthetic management of two patients with alkaptonuric ochronosis for total knee arthroplasty].

Authors:  Betul Kozanhan
Journal:  Braz J Anesthesiol       Date:  2017-05-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.